Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Guidance and Visibility -- Ignore unavailable to you. Want to Upgrade?

To: SirRealist who wrote (62199)	7/25/2002 9:14:33 AM
From: Bob Biersack	Respond to of 208838

BREL**BioReliance 2nd-qtr profit soars ROCKVILLE, Md., July 24 (Reuters) - BioReliance Corp. (NasdaqNM:BREL - News), which conducts clinical trials for drug companies, on Wednesday said its quarterly earnings rose more than three-fold on improved profit margins and a jump in sales. The Rockville, Maryland company said its second-quarter profit climbed to $2.8 million, or 31 cents a share, from $900,000, or 10 cents in the year-earlier period